OrthoPediatrics Corp. (KIDS) Stock

About OrthoPediatrics Corp.

OrthoPediatrics Corp. is led by CEO David R. Bailey, publicly traded since 2017.

OrthoPediatrics Corp. (KIDS) stock trades at $24.50 with a market capitalization of $639.69M. The stock is valued at a negative price-to-earnings (P/E) ratio of -13.19, reflecting a net loss over the last twelve months, price-to-book of 1.54, price-to-sales of 2.25. Over the past 52 weeks the stock has ranged between $14.42 and $26.74, and currently trades 8.4% below its 52-week high.

On profitability, OrthoPediatrics Corp. generates a return on equity (ROE) of -11.53% (negative, reflecting a net loss), return on capital employed of -4.97%, an operating margin of -12.29%, a net profit margin of -15.72%.

OrthoPediatrics Corp. by the numbers, 2016–2025

Between 2016 and 2025 OrthoPediatrics Corp. reported revenue of $37.0M rising to $236.0M, a change of +537.8% across 10 years. Compounded, revenue has grown 27.1% a year over five years, 24.6% over three, 15.1% over the last twelve months. Net profit fell to $-40.0M.

Operating margin went from -16.4% in 2016 to -12.3% in 2025, a gain of 4.2 percentage points. The most recent net margin is -15.72%. On a trailing twelve-month basis to Jun '26, revenue is $253.0M and net profit $-40.0M.

Borrowings rose from $18.0M to $100.0M, cash from operations was $-5.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -6.9% over five years, and was -11.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

OrthoPediatrics Corp. (KIDS) — frequently asked questions